BACKGROUND: Ipilimumab improves survival in metastatic melanoma patients. This population frequently develops brain metastases, which have been associated with poor survival and are often treated with radiation. Therefore, outcomes following ipilimumab and radiation are of interest, especially given...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!